Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Double-Blind Placebo-Controlled Trial of Mosapride in Patients With Constipation-Predominant Irritable Bowel Syndrome

NCT00742872 is registered in ClinicalTrials.gov with American University of Beirut Medical Center as lead sponsor.

NCT NCT00742872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00742872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Double-Blind Placebo-Controlled Trial of Mosapride in Patients With Constipation-Predominant Irritable Bowel Syndrome
Lead sponsor
American University of Beirut Medical Center
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2008
Completion date
June 30, 2010
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation-predominant irritable bowel syndrome